VUMC — Amsterdam

Public research footprint of VUMC, compiled from the ClinicalTrials.gov public registry.

387

Registered studies

150

Active

Recruiting now

138

Completed

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Carcinoma, Non-Small-Cell Lung · Bronchiectasis · Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS)

Recently updated registry entries

NCT07707895 — DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With… (Not Yet Recruiting)
NCT06330064 — A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects… (Recruiting)
NCT06465953 — Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at VUMC?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.